Carl L. Gordon
DirectoratKeros Therapeutics· In proxies 2024–2025
Carl L. Gordon sits on 7 public boards.
Boards1
- Keros TherapeuticsDirector · 4 yr on the boardIndependentCompensation—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Keros TherapeuticsPublic company · 2 yr
- Director2024 – Present · 2 yrStock in role -71%
- Adicet Bio, Inc.Public company
- Director? – PresentNo stock prices for these years
- ArriVent Biopharma, Inc.Public company
- Director? – PresentNo stock prices for these years
- Compass Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Lomond Therapeutics Holdings, Inc.Public company
- Director? – PresentNo stock prices for these years
- MBX Biosciences, Inc.Public company
- Director? – PresentNo stock prices for these years
- Terns Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?